1. Cost-effectiveness of Lifestyle Africa: an adaptation of the diabetes prevention programme for delivery by community health workers in urban South Africa.
- Author
-
Whittington, Melanie D., Goggin, Kathy, Tsolekile, Lungiswa, Puoane, Thandi, Fox, Andrew T., Resnicow, Ken, Fleming, Kandace K., Smyth, Joshua M., Materia, Frank T., Hurley, Emily A., Vitolins, Mara Z., Lambert, Estelle V., Levitt, Naomi S., and Catley, Delwyn
- Subjects
DIABETES prevention ,GLYCOSYLATED hemoglobin ,MEDICAL care ,INTERVIEWING ,HUMAN services programs ,HEALTH behavior ,COST effectiveness ,RESEARCH funding ,METROPOLITAN areas ,BEHAVIOR modification ,HEALTH care rationing - Abstract
Lifestyle Africa is an adapted version of the Diabetes Prevention Program designed for delivery by community health workers to socioeconomically disadvantaged populations in low- and middle-income countries (LMICs). Results from the Lifestyle Africa trial conducted in an under-resourced community in South Africa indicated that the programme had a significant effect on reducing haemoglobin A1c (HbA1c). To estimate the cost of implementation and the cost-effectiveness (in cost per point reduction in HbA1c) of the Lifestyle Africa programme to inform decision-makers of the resources required and the value of this intervention. Interviews were held with project administrators to identify the activities and resources required to implement the intervention. A direct-measure micro-costing approach was used to determine the number of units and unit cost for each resource. The incremental cost per one point improvement in HbA1c was calculated. The intervention equated to 71 United States dollars (USD) in implementation costs per participant and a 0.26 improvement in HbA1c per participant. Lifestyle Africa reduced HbA1c for relatively little cost and holds promise for addressing chronic disease in LMIC. Decision-makers should consider the comparative clinical effectiveness and cost-effectiveness of this intervention when making resource allocation decisions. Trial registration is at ClinicalTrials.gov (NCT03342274). [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF